KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Novavax (NVAX) over the last 16 years, with Q3 2025 value amounting to -$11.7 million.

  • Novavax's Other Working Capital Changes fell 13115.72% to -$11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$621.5 million, marking a year-over-year decrease of 33987.42%. This contributed to the annual value of -$354.1 million for FY2024, which is 20091.8% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Other Working Capital Changes is -$11.7 million, which was down 13115.72% from -$4.9 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Other Working Capital Changes peaked at $549.6 million during Q1 2021, and registered a low of -$874.6 million during Q4 2022.
  • For the 5-year period, Novavax's Other Working Capital Changes averaged around -$18.1 million, with its median value being -$4.9 million (2025).
  • As far as peak fluctuations go, Novavax's Other Working Capital Changes skyrocketed by 1225624.86% in 2021, and later crashed by 36266.54% in 2022.
  • Novavax's Other Working Capital Changes (Quarter) stood at $333.0 million in 2021, then crashed by 362.67% to -$874.6 million in 2022, then soared by 124.23% to $211.9 million in 2023, then tumbled by 100.43% to -$913000.0 in 2024, then plummeted by 1182.8% to -$11.7 million in 2025.
  • Its last three reported values are -$11.7 million in Q3 2025, -$4.9 million for Q2 2025, and -$604.0 million during Q1 2025.